(Q24632276)
Statements
Pharmacologic disruption of Polycomb Repressive Complex 2 inhibits tumorigenicity and tumor progression in prostate cancer (English)
0 references
2011
0 references
10
0 references
40
0 references
1
0 references
1 reference
1 reference
1 reference
1 reference